Wolwo Pharma
30035723.660.13% ( +0.03 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Wolwo Pharma(300357) the Revenue is 252.84 M (+10.67%);the EBIT is 96.89 M (+26.33%);the EPS is 0.228 (+60.35%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.25B10.67%
----
----
EBIT
0.10B26.33%
----
----
EPS
0.227760.35%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf